The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Robert Montgomery
Consulting or Advisory Role - Daiichi Sankyo/UCB Japan; Janssen Scientific Affairs
Research Funding - Clovis Oncology (Inst); Inmune Bio; Janssen Oncology (Inst); Merck/Genentech
 
Lauren Howard
Consulting or Advisory Role - Tempus
 
Susan Halabi
Employment - ASCO
Consulting or Advisory Role - BeiGene; Bristol-Myers Squibb; CG Oncology; J&J; Sanofi
 
Terry Hyslop
No Relationships to Disclose
 
Bonnie LaCroix
No Relationships to Disclose
 
Alvin Matsumoto
No Relationships to Disclose
 
Julia Hurrelbrink
No Relationships to Disclose
 
Julie Kephart
No Relationships to Disclose
 
Julia Rasmussen
No Relationships to Disclose
 
Marco Reyes-Martinez
No Relationships to Disclose
 
Kellie Shobe
No Relationships to Disclose
 
Steven Gray
No Relationships to Disclose
 
Monika Anand
No Relationships to Disclose
 
Steven Patierno
No Relationships to Disclose
 
Andrew Armstrong
Consulting or Advisory Role - Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Boundless Bio; Bristol-Myers Squibb; Cytogen; Exelixis; GoodRx; Janssen; Merck; Myovant Sciences; Novartis; Pfizer; Precede Bio; Sumitomo Pharma Oncology
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); pathos (Inst); Pfizer (Inst); Syntrix Biosystems (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture technology (Inst)
Travel, Accommodations, Expenses - Astellas Scientific and Medical Affairs Inc
 
Elahe Mostaghel
No Relationships to Disclose
 
Daniel George
Leadership - Capio BioSciences
Stock and Other Ownership Interests - BMS; Pfizer
Honoraria - Astellas Pharma; AstraZeneca; Axess Oncology; Bayer; Candel Therapeutics; Eisai; IDEOlogy Health; Janssen Oncology; Merck; Millennium Medical Publishing; Novartis; OncLive; Pfizer; Sumitomo; UroToday
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Candel Theraputics; Janssen; Merck Sharp & Dohme; Michael J. Hennessy Associates; Novartis; Pfizer; Physicans' Education Resource
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Convergent Therapeutics (Inst); Corvus Pharmaceuticals (Inst); Exelixis (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Expert Testimony - Exelixis
Travel, Accommodations, Expenses - Bayer; Exelixis; Merck; Novartis; Pfizer
 
Jennifer Freedman
Stock and Other Ownership Interests - TheraSplice
Research Funding - Janssen Scientific Affairs (Inst)
Patents, Royalties, Other Intellectual Property - Inventor, 15/344,222, "Biomarkers for the Identification of Prostate Cancer and Methods of Use", filed November 4, 2016, pending.; Inventor, PCT/US19/23670, “Splice-Switching Oligonucleotides and Methods of Use”, filed March 22, 2019, notice of allowance June 7, 2021.